Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells 1,878 Shares of Stock

Phreesia, Inc. (NYSE:PHR) insider Yvonne Hui sold 1,878 shares of the firm’s stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $44,790.30. Following the sale, the insider now directly owns 28,449 shares in the company, valued at approximately $678,508.65. This trade represents a 6.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Yvonne Hui also recently made the following trade(s):

• On Friday, January 24th, Yvonne Hui sold 127 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $3,556.00.
• On Tuesday, January 14th, Yvonne Hui sold 362 shares of Phreesia stock. The stock was sold at an average price of $26.38, for a total value of $9,549.56.
• On Friday, January 10th, Yvonne Hui sold 388 shares of Phreesia stock. The stock was sold at an average price of $27.85, for a total value of $10,805.80.

Phreesia Trading Up 0.3 %

NYSE:PHR opened at $24.06 on Friday. The stock has a market capitalization of $1.41 billion, a price-to-earnings ratio of -16.37 and a beta of 0.82. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $30.53. The stock has a fifty day moving average price of $26.57 and a two-hundred day moving average price of $24.26. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Institutional Investors Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Johnson Financial Group Inc. increased its holdings in Phreesia by 381.3% during the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after acquiring an additional 896 shares in the last quarter. R Squared Ltd purchased a new position in Phreesia during the fourth quarter worth about $30,000. BankPlus Trust Department acquired a new stake in shares of Phreesia in the fourth quarter worth approximately $34,000. Quarry LP boosted its holdings in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock valued at $71,000 after purchasing an additional 1,923 shares during the last quarter. Finally, Venturi Wealth Management LLC purchased a new stake in Phreesia during the fourth quarter valued at about $76,000. 92.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on PHR. Piper Sandler reaffirmed an “overweight” rating and set a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and increased their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Citigroup lifted their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Canaccord Genuity Group raised their price objective on shares of Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday, March 13th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Phreesia presently has an average rating of “Buy” and an average target price of $31.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.